STEPHEN DAVIS - 15 Jun 2021 Form 4 Insider Report for BELLICUM PHARMACEUTICALS, INC

Role
Director
Signature
/s/ Richard A. Fair, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
15 Jun 2021
Net transactions value
$0
Form type
4
Filing time
07 Jul 2021, 20:25:40 UTC
Next filing
19 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLCM Stock Option (right to buy) Award $0 +6,500 $0.000000 6,500 15 Jun 2021 Common Stock 6,500 $3.05 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.